BioCentury
ARTICLE | Company News

Protagen, Novartis deal

January 6, 2017 8:36 PM UTC

Protagen said it used its SeroTag technology to successfully identify predictive and stratification biomarkers, which Novartis will use in the development of an undisclosed autoimmune drug. SeroTag us...

BCIQ Company Profiles

Novartis AG

Protagen AG